A brutal 12 months for Teladoc Health Inc (NYSE:TDOC) went from bad to much worse on Thursday when the stock dropped another 43% after the company reported much larger-than-expected losses in the first quarter and slashed its 2022 guidance.
On Wednesday, Teladoc reported a whopping EPS loss of $41.58 per share, far worse than the 60-cent per-share loss analysts were expecting. The large loss was driven by a $6.6 billion noncash goodwill impairment charge.
